Grünenthal Limited
TOR Building
St Cloud Way
Maidenhead SL6 8BN
Phone: +44 0800 254 5540

For Medical Information, Reporting Safety and Quality Related Issues see here

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 100 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global business.

... History

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact on society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

... Responsibility

Although firmly rooted in Germany, today we’re very much a growing global business, represented in 27 countries and maintaining production sites in five.

... Global Capabilities

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for Funding

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Ationdo.

... Ationdo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Nebido.

... Nebido

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Palexia.

... Palexia

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Qutenza.

... Qutenza

We are dedicated to creating a better future for our patients, Read the package leaflet information to find out more about Ralvo.

... Lidocaine Grunenthal

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Tramacet.

... Tramacet

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Versatis.

... Versatis

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Vimovo .

... Vimovo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zydol.

... Zydol

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zomig.

... Zomig

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs. Read the package leaflet information to find out more about our products.

... Reporting Safety and Quality Related complaints

Grünenthal Transforming lives through science

Transforming lives through science

Transforming lives through science

Our Vision: A World Free of Pain

Grünenthal is a global leader in pain management and related diseases.

As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.

Locations

27

We are present in 27 countries with affiliates in Europe, Latin America, and the US.

Market presence

100

Our products are available in approx. 100 countries.

Employees

4,400

4,400 employees work for our group worldwide.

What we do

As a fully integrated research & development company we bring innovative pain treatments and state-of-the-art technologies to patients.

Learn more about us

Annual Report 2023/24

4,400 Grünenthal employees worldwide join forces every day to drive progress towards our vision of a World Free of Pain. Together, we achieved record revenues in 2023. And our scientists made important progress with developing innovative medicines for pain patients.

Our most recent report shares information about our company’s strategy, highlight projects and financial performance.

Check out the Grünenthal Report.

Responsibility Report 2023

Grünenthal’s strategy and culture are closely tied to its deep commitment to conducting business responsibly. We aim to have a net-positive impact on patients, employees, partners, and wider society. Each year, we publish our progress in a detailed and externally audited report – in line with the Global Reporting Initiative (GRI) standards.

Check out our latest Responsibility Report.

Our passion is innovation!

Pioneering thinkers

Our passion is innovation. We are driven to seek new solutions for patients with severe diseases and high unmet medical needs – and make these solutions accessible to patients.

Ready to create a brighter future for our patients?

Careers

Ready to create a brighter future for our patients? With us, let your passion and ideas flow and drive innovation to improve our patients’ lives.

Join forces.

Make an impact.

Innovate for a world free of pain.

Work with Grünenthal

M-N/A-UK-04-24-0004 - April 2024